A pilot of two technologies, Bleepa and CareLocker, has been commissioned by Sussex Integrated Care System, to take place at Queen Victoria Hospital NHS Foundation Trust (QVH).
To act as one of the Community Diagnostic Centres Exemplar sites, Bleepa and CareLocker will be used as the digital infrastructure to facilitate patient specific pathways through the centres, linking primary and secondary care settings.
The programme aims to help reduce the elective care backlog by bringing diagnostic investigations closer to patients in community settings, and reducing the need for patients to attend hospital for diagnostic tests.
The pilot will use the company’s software to provide a digital clinical communication platform to allow investigations to be captured and presented to clinicians in primary and secondary care settings for review, discussion and planning onward management. The pathway record will then be stored centrally using CareLocker.
Dr Tom Oakley, CEO of Feedback, commented: “The CDC programme sees the creation of an entirely new care setting and it needs the right digital infrastructure to ensure that it is fully integrated in order to deliver the intended system benefits and to drive down the elective care backlog.
“This is a once-in-a-generation opportunity to redesign care pathways and service delivery to our citizens. Connecting teams across care settings and presenting clinical data to drive faster decision making is precisely what Bleepa is designed to deliver. The CDC programme is an exciting opportunity for us to demonstrate our technology at a regional level and we believe that this will lead to a number of broader opportunities for Bleepa and our supporting technologies within the CDC programme and beyond.”
Dr Ian Francis, Deputy Medical Director at QVH, added: “We are very pleased to be working with Feedback and believe that the Bleepa platform will enable us to deliver cross-regional care aligned to designated clinical pathways. The patient-centric approach is core to our CDC proposal and the combination of Bleepa and CareLocker will allow us to deliver a connected CDC programme that maximises the impact for staff, patients and the wider system.”
The pilot is expected to run until March 2022 and will initially focus on delivering targeted CDC pathways in specific clinical areas such as respiratory and cardiology.
